VEGFA and metastatic neoplasm: The tumor-promoting properties of activated myofibroblasts are implied by studies that demonstrate the failure of antiangiogenic therapies that target VEGF-pathways of metastatic tumors, despite their effectiveness against primary tumors40,41.